Abstract
Exogenous glucocorticoids (GCs) are recommended at low doses and as long-term treatment in chronic immune/inflammatory diseases and exert a sort of “replacement therapy” of the decreased endogenous cortisol availability, due...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
